These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9656355)

  • 1. Cancer genes and cholangiocarcinoma.
    Petmitr S
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 1():80-4. PubMed ID: 9656355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients.
    Petmitr S; Pinlaor S; Thousungnoen A; Karalak A; Migasena P
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):71-5. PubMed ID: 9740272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Mutations in human cholangiocarcinoma: a review.
    Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD
    Liver Int; 2005 Aug; 25(4):704-16. PubMed ID: 15998419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of genetic changes in intrahepatic cholangiocarcinoma induced by thorotrast.
    Kamikawa T; Amenomori M; Itoh T; Momoi H; Hiai H; Machinami R; Ishikawa Y; Mori T; Shimahara Y; Yamaoka Y; Fukumoto M
    Radiat Res; 1999 Dec; 152(6 Suppl):S118-24. PubMed ID: 10564951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.
    Kang YK; Kim WH; Lee HW; Lee HK; Kim YI
    Lab Invest; 1999 Apr; 79(4):477-83. PubMed ID: 10212000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.
    Kiba T; Tsuda H; Pairojkul C; Inoue S; Sugimura T; Hirohashi S
    Mol Carcinog; 1993; 8(4):312-8. PubMed ID: 8280380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique.
    Wattanasirichaigoon S; Tasanakhajorn U; Jesadapatarakul S
    J Med Assoc Thai; 1998 May; 81(5):316-23. PubMed ID: 9623030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of p53 mutations for a mutational signature in human intrahepatic cholangiocarcinoma.
    Khan SA; Taylor-Robinson SD; Carmichael PL; Habib N; Lemoine NR; Thomas HC
    Int J Oncol; 2006 May; 28(5):1269-77. PubMed ID: 16596244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma.
    Jinawath N; Chamgramol Y; Furukawa Y; Obama K; Tsunoda T; Sripa B; Pairojkul C; Nakamura Y
    Hepatology; 2006 Oct; 44(4):1025-38. PubMed ID: 17006947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].
    Wang X; Zhang J; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
    Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
    Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
    Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C
    J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
    Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
    Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan.
    Suzuki H; Isaji S; Pairojkul C; Uttaravichien T
    J Hepatobiliary Pancreat Surg; 2000; 7(2):206-11. PubMed ID: 10982615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas.
    Ohashi K; Tsutsumi M; Nakajima Y; Noguchi O; Okita S; Kitada H; Tsujiuchi T; Kobayashi E; Nakano H; Konishi Y
    Jpn J Clin Oncol; 1994 Dec; 24(6):305-10. PubMed ID: 7830335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelotype analysis of intrahepatic cholangiocarcinoma.
    Kang YK; Kim YI; Kim WH
    Mod Pathol; 2000 Jun; 13(6):627-31. PubMed ID: 10874666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Descriptive epidemiology of intrahepatic cholangiocarcinoma].
    Tsukuma H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():25-32. PubMed ID: 11761949
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms.
    Songserm N; Promthet S; Sithithaworn P; Pientong C; Ekalaksananan T; Chopjitt P; Parkin DM
    Cancer Epidemiol; 2012 Apr; 36(2):e89-94. PubMed ID: 22189445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for cholangiocarcinoma.
    Ben-Menachem T
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):615-7. PubMed ID: 17625428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
    Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
    J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.